Clinical Trials List
Protocol NumberGR41986
Completed
2020-09-01 - 2024-09-18
Phase III
Recruiting3
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 鄭捷尹 Division of Ophthalmology
- 童筱凡醫師 Division of Ophthalmology
- 莊智鈞 Division of Ophthalmology
- PO-LIN CHEN Division of Ophthalmology
- San-Ni Chen Division of Ophthalmology
- 謝明潔 Division of Ophthalmology
- 張晉維醫師 Division of Ophthalmology
- 李昆憲 Division of Ophthalmology
- 胡毓真 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wei-Chi WU Division of Ophthalmology
- 沈惠真 無
- 劉珍吟 Division of Ophthalmology
- 陳冠任 Division of Ophthalmology
- 簡如伶 無
- 陳墩祿 Division of Ophthalmology
- 周宏達 Division of Ophthalmology
- Chi-Chun Lai Division of Ophthalmology
- 陳彥伯 Division of Ophthalmology
- 康祐銓 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
11-15 participants
-
Global
680 participants
